期刊文献+

实时荧光定量PCR检测野生型p53介导蛋白磷酸酶mRNA在非小细胞肺癌中的表达 被引量:1

Expression of Wip1 mRNA in Non-small Cell Lung Cancer by Real-time PCR
下载PDF
导出
摘要 【目的】荧光染料Ⅰ(SYBR GreenⅠ)是一种较为常用的非探针类定量PCR的方法,其结果具有一定特异性。本研究的目的是建立检测野生型p53介导蛋白磷酸酶(Wip1)mRNA的SYBR GreenⅠ实时定量PCR的方法,了解肺癌组织及其远癌正常肺组织中Wip1的表达水平,研究肺癌组织中Wip1的表达水平与各种临床病理特征之间的关系。【方法】利用相对定量的方法检测44例肺癌及相应远癌正常肺组织中Wip1mRNA相对于β-actin mRNA的表达量,进行相对定量分析。【结果】44例非小细胞肺癌(NSCLC)及相应远癌正常肺组织均有Wip1mRNA的表达,其中17例非小细胞肺癌中Wip1mRNA高表达,占38.6%,两者表达差异有统计学意义(Ratio=2.1644±1.394,P<0.05);分化程度低的肺癌组织中Wip1mRNA表达量显著高于分化程度高者(F=5.08,P=0.013)。【结论】SYBR GreenⅠ实时定量PCR方法可以成功地检测Wip1基因的表达量。初步检测结果显示Wip1可能是一种肺癌发生发展过程中的致癌因素。 [Objective] The aim of this study was to establish a quantitative SYBR Green Ⅰ real-time PCR method for detection of wide-type p53-induced phosphatase 1 (Wipl or PPM1D) gene expression level in non-small cell lung cancer (NSCLC), and to investigate the relationship between Wipl mRNA expression level and the clinicopathological characters. [Method] Real-time PCR was employed to determine the expression level of Wipl mRNA in 44 specimens of NSCLC tissues and their adjacent normal tissues. [Results] In the 44 specimens, the expression of Wipl mRNA in both cancer tissues and adjacent normal lung tissues were positive. Wipl gene was overexpressed in 17 specimens among 44 NSCLC specimens. The rate was 38.6%. The relative level of Wipl mRNA in NSCLC tissues was significantly higher than the adjacent normal lung tissues (Ratio = 2.1644 ± 1.394, P 〈 0.01). The expression of Wipl mRNA was also correlated with pathological staging (F = 5.08, P = 0.013). [Conclusion] The established SYBR Green Ⅰ quantitative real-time PCR method can successfully detect the expression level of Wipl mRNA. The results suggested that Wipl may be involved in the development of NSCLC.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2009年第4期463-467,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省医学科技基金(2007C24004)
关键词 非小细胞肺癌 Wip1基因 实时定量聚合酶链反应 non-small cell lung cancer Wipl real time fluoresene quantitative PCR
  • 相关文献

参考文献11

  • 1Fiscella M,Zhang H,Fan S,et al.Wip1,a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner[J].Proc Natl Acad Sci USA,1997,94(12):6048-6053.
  • 2Bulavin DV,Demidov ON,Saito S,et al.Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity[J].Nat Genet,2002,31(2):210-215.
  • 3Li J,Yang Y,Peng Y,et al.Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23[J].Nat Genet,2002,31(2):133-134.
  • 4Yu E,Ahn YS,Jang SJ,et al.Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers[J].Breast Cancer Res Treat,2007,101(3):269-278.
  • 5Hirasawa A,Saito OF,Inoue J,et al.Association of 17q21-q24 gain in ovarian clear cell adenocarcinomase with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets[J].Clin Cancer Res,2003,9(6):1995-2004.
  • 6Sain OF,Imoto I,Inoue J,et al.PPM1D is a protential target for 17q gain in neuroblastoma[J].Cancer Res,2003,63(8):1876-1883.
  • 7Loukopoulos P,Shibate T,Katoh H,et al.Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma:Identification of genetic indication that predict patien outcome[J].Cancer Sci,2007,98(3):392-400.
  • 8Fuku T,Semba S,Yutori H,et al.Increased wide-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma[J].Pathol Int,2007,57(9):566-571.
  • 9Mendrzyk F,Radlwimmer B,Joos S,et al.Genomic and protein expression profiling identifies CDK6 as novel indepent prognostic marker in medulloblastoma[J].J Clin Oncol,2005,23(34):8853-8862.
  • 10Heid CA,Stevens J,Livak KJ,et al.Real time quantitative PCR[J].Genome Res,1996,6(10):986-994.

同被引文献6

  • 1Bulavin DV, Demidov ON, Saito S, et al. Amplification of PPM119 in human tumors abrogates p53 tumor-suppressor activity. Nat Genet, 2002, 31 (2) :210-215.
  • 2Loukopoulos P, Shibata T, Katoh H, et al. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma : identification of genetic indicators that predict patient outcome. Cancer Sci, 2007,98 (3) :392-400.
  • 3Bulavin DV, Phillips C, Nannenga B, et al. Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK- mediated activation of the p16 (Ink4a) -pl9 (Aft) pathway. Nat Genet, 2004,36(4) :343-350.
  • 4Saito-Ohara F, Imoto I, Inoue J, et al. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res, 2003,63 (8):1876- 1883.
  • 5Hickson JA, Fong B, Watson PH, et al. PP2Cdelta (Ppmld, WIP1) , an endogenous inhibitor of p38 MAPK, is regulated alongwith Trp53 and Cdkn2a following p38 MAPK inhibition during mouse preimplantation development. Mol Reprod Dev, 2007,74 (7) : 821- 834.
  • 6赵吉星,张伟,孙磊,罗红鹤,顾勇.Wip1在非小细胞肺癌组织及细胞中的表达[J].中国病理生理杂志,2009,25(9):1731-1735. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部